Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes ...
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex ...
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel ...
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology ...
Dealbreaker on MSN3d
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the WorldAscentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...
Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...
Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
4D Molecular Therapeutics Inc. 1.29% $218.19M ...
After hours: January 28 at 6:23:43 PM EST Loading Chart for PBYI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback